Case Report

Paraneoplastic polyarthritis as the first manifestation of lingual carcinoma

Volume 6 · Issue 1 Publish Date: September 3, 2019
Full Text PDF
DOI
Andrea Briones-Figueroa
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Walter Alberto Sifuentes-Giraldo
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Rosario Carrillo-Gijón
Department of Pathology, Ramón y Cajal University Hospital, Madrid, Spain
José Luis Morell-Hita
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Briones-Figueroa, A., Sifuentes-Giraldo, W. A., Carrillo-Gijón, R., & Morell-Hita, J. L. (2019). Paraneoplastic polyarthritis as the first manifestation of lingual carcinoma. European Journal of Rheumatology, 6(1), 55–56. https://doi.org/10.5152/eurjrheum.2018.18068
Full Text Full Text PDF

Abstract

Abstract

 

Paraneoplastic polyarthritis is an inflammatory arthritis, is usually seronegative, and has a temporal and pathophysiological relationship with an underlying malignancy. Although head and neck tumors may be a cause of paraneoplastic polyarthritis, its association with tongue carcinoma has not been previously reported. We present the case of a 69-year-old man who was a former smoker and presented with polyarthritis since 2 months in the wrists, proximal interphalangeal joints, knees, and elbows, with increased levels of acute-phase reactants; negativity for rheumatoid factor, anticitrullinated cyclic peptide antibody, and antinuclear antibody; and negative results for crystals and microorganisms in the synovial fluid. Cervical computed tomography and posterior rhinoscopy were performed, which detected an asymptomatic lesion on the base of the tongue, whose biopsy was compatible with nonkeratinizing squamous cell carcinoma. Polyarthritis did not respond to glucocorticoids at medium doses (oral prednisone 20 mg/day) but progressively resolved after the initiation of antineoplastic therapy.

Paraneoplastic polyarthritis is an inflammatory arthritis, is usually seronegative, and has a temporal and pathophysiological relationship with an underlying malignancy. Although head and neck tumors may be a cause of paraneoplastic polyarthritis, its association with tongue carcinoma has not been previously reported. We present the case of a 69-year-old man who was a former smoker and presented with polyarthritis since 2 months in the wrists, proximal interphalangeal joints, knees, and elbows, with increased levels of acute-phase reactants; negativity for rheumatoid factor, anticitrullinated cyclic peptide antibody, and antinuclear antibody; and negative results for crystals and microorganisms in the synovial fluid. Cervical computed tomography and posterior rhinoscopy were performed, which detected an asymptomatic lesion on the base of the tongue, whose biopsy was compatible with nonkeratinizing squamous cell carcinoma. Polyarthritis did not respond to glucocorticoids at medium doses (oral prednisone 20 mg/day) but progressively resolved after the initiation of antineoplastic therapy.

 

Cite this article as: Briones-Figueroa A, Sifuentes-Giraldo WA, Carrillo-Gijón R, Morell-Hita JL. Paraneoplastic polyarthritis as the first manifestation of lingual carcinoma. Eur J Rheumatol 2019; 6(1): 52-3.

Article Info
Published In
Journal European Journal of Rheumatology
Volume / Issue Volume 6 · Issue 1
Pages 55-56
History
Published Online September 3, 2019
Copyright
Affiliations
Andrea Briones-Figueroa
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Walter Alberto Sifuentes-Giraldo
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Rosario Carrillo-Gijón
Department of Pathology, Ramón y Cajal University Hospital, Madrid, Spain
José Luis Morell-Hita
Department of Rheumatology, Ramón y Cajal University Hospital, Madrid, Spain
Cite this Article
Briones-Figueroa, A., Sifuentes-Giraldo, W. A., Carrillo-Gijón, R., & Morell-Hita, J. L. (2019). Paraneoplastic polyarthritis as the first manifestation of lingual carcinoma. European Journal of Rheumatology, 6(1), 55–56. https://doi.org/10.5152/eurjrheum.2018.18068
Share
Outlines